| Enumerate the hormones secreted by anterior pituitary and list the factors stimulating and inhibiting secretion of growth hormone (DNB 2010/2)3+7 | 594 | 2010 |
| A) Enumerate hormones secreted by anterior pituitary. B) Factors stimulating and inhibiting secretion of growth hormone (DNB 2015/1)3+7 | 594 | 2015 |
| Hypothalamic Pituitary axis (DNB 2023/1)5 | 594 | 2023 |
| Indications of Growth Hormone Therapy (DNB 1993/2)10 | 595 | 1993 |
| What are the causes of Dwarfism? How will you investigate such a case (DNB 1997/2)15 | 595 | 1997 |
| Indication of growth hormone therapy in paediatrics (DNB 2017/1)5 | 595 | 2017 |
| Growth Hormone in Pediatric practise (DNB 2019/2)5 | 595 | 2019 |
| Enumerate the various functions of growth hormone and describe indications of growth hormone therapy (DNB 2020/1)5 | 595 | 2020 |
| Diagnosis and management of Growth hormone deficiency (DNB 2022/1)5 | 595 | 2022 |
| Growth hormone therapy (DNB 2022/2)5 | 595 | 2022 |
| Indications of growth hormone replacement therapy (DNB 2023/1)5 | 595 | 2023 |
| How will you assess a child presenting with features of Diabetes Insipidus (DNB 2006/1)10 | 596 | 2006 |
| A 4-year-old child presents with polydipsia and polyuria. How will you establish a diagnosis of diabetes insipidus in this case? Discuss its management (DNB 2008/1)10 | 596 | 2008 |
| Diagnostic approach for a child who presented with polyuria and polydipsia (DNB 2010/1)10 | 596 | 2010 |
| Outline the diagnostic criteria of diabetes insipidus. Discuss the management of nephrogenic diabetes insipidus (DNB 2010/2)4+6 | 596 | 2010 |
| Discuss approach to the diagnosis of a child presenting with polyuria and polydipsia (DNB 2013/2)10 | 596 | 2013 |
| Causes, clinical presentation, investigations and management of diabetes insipidus (DNB 2015/1)1+2+3+4 | 596 | 2015 |
| A child with suspected diabetes insipidus is brought to hospital. How will you approach, investigate and manage this patient? (DNB 2016/1)2+3+5 | 596 | 2016 |
| Approach to a 2 years old boy with polyuria (DNB 2022/1)5 | 596 | 2022 |
| Management of central diabetes insipidus (DNB 2024/1)5 | 596 | 2024 |
| SIADH (DNB 1999/1)10 | 597 | 1999 |
| SIADH (DNB 1999/2)10 | 597 | 1999 |
| How will you diagnose and treat SIADH in a child (DNB 2006/1)5 | 597 | 2006 |
| Outline the diagnostic criteria for SIADH. Discuss its etiopathogenesis (DNB 2012/1)6+4 | 597 | 2012 |
| Write short notes on the evaluation and treatment for a child with: SIADH (DNB 2014/1)5 | 597 | 2014 |
| Diagnostic criteria for SIADH (DNB 2017/2)4 | 597 | 2017 |
| Diagnostic criteria for SIADH (DNB 2021/1)5 | 597 | 2021 |
| Diagnosis and management of SIADH (DCH 2024/1)5 | 597 | 2024 |
| A 5-year-old boy has attained a height of 137 cm. What could be the cause(s) for this situation and which specific clinical pointers may be useful for determining the cause. How will you evaluate this child for an underlying endocrinological disorder? (DNB 2013/2) 6+4 | 598 | 2013 |
| Discuss the normal physiology of puberty and its relation to sexual development (DNB 2009/1)4+6 | 599 | 2009 |
| Physiology of puberty in boys and girls (DNB 2010/1)10 | 599 | 2010 |
| Normal changes during puberty (DCH 2024/1)5 | 599 | 2024 |
| Define delayed puberty in a male child. List the possible causes. Describe changes in male genitals in different stages of sexual maturation (DNB 2008/2)10 | 600 | 2008 |
| Outline the diagnostic approach to a 14 years old boy with infantile genitalia (DNB 2010/1)10 | 600 | 2010 |
| Define and classify precocious puberty in boys according to its etiology. Outline the approach for investigating a boy with precocious puberty (DNB 2011/1)2+4+4 | 600 | 2011 |
| Define delayed puberty. Describe its etiology and diagnostic evaluation (DNB 2013/2)2+4+4 | 600 | 2013 |
| Write short notes on the evaluation and treatment for a child with: Virilisation (DNB 2014/1)5 | 600 | 2014 |
| Define precocious puberty in boys. Enumerate causes of precocious puberty in boys (DNB 2014/2)5 | 600 | 2014 |
| Premature thelarche (DNB 2018/1)4 | 600 | 2018 |
| Approach to delayed puberty (DNB 2017/2)5 | 600 | 2017 |
| Diagnostic approach to precocious puberty in girls (DNB 2018/2)5 | 600 | 2018 |
| Investigation and management of delayed puberty (DNB 2019/2)5 | 600 | 2019 |
| Precocious puberty (DNB 2020/1)5 | 600 | 2020 |
| Diagnosis of delayed puberty in males (DNB 2022/2)5 | 600 | 2022 |
| Define precocious puberty and its causes (DNB 2023/1)5 | 600 | 2023 |
| Etiology and evaluation of a 4-year-old girl with precocious puberty (DCH 2024/1)5 | 600 | 2024 |
| Precocious puberty in a 6-year-old boy: approach to diagnosis and management (DNB 2024/2)5 | 600 | 2024 |
| What are the changes seen in Thyroid Hormone levels around birth? Describe the salient features of Neonatal Thyroid Screening programme (DNB 2006/1)10 | 601 | 2006 |
| Thyroid hormone synthesis and its derangements (DNB 2010/1)6+4 | 601 | 2010 |
| Interpretation of thyroid function tests (DNB 2019/2)5 | 601 | 2019 |
| Diagnosis of Congenital Hypothyroidism (DNB 1995/1)15 | 603 | 1995 |
| Clinical features of Cretinism in newborn babies (DNB 1997/1)10 | 603 | 1997 |
| Endemic Cretinism (DNB 1999/2)15 | 603 | 1999 |
| Congenital Hypothyroidism (DNB 2000/1)15 | 603 | 2000 |
| Etiopathology of Congenital Hypothyroidism (DNB 2000/2)15 | 603 | 2000 |
| Congenital Hyperthyroidism (DNB 2007/1)10 | 603 | 2007 |
| Neonatal Thyroid Screening (DNB 2007/2)10 | 603 | 2007 |
| Discuss causes, clinical features and management of Acquired Hypothyroidism (DNB 2007/2)10 | 603 | 2007 |
| Discuss the synthesis of thyroid Hormones. Outline the causes of congenital hypothyroidism and a brief comment on neonatal thyroid screening (DNB 2009/1)3+7 | 603 | 2009 |
| Describe in brief the etiology, clinical features, diagnostic investigations and management of congenital hypothyroidism (DNB 2011/1)2+2+3+3 | 603 | 2011 |
| Enlist common causes of acquired hypothyroidism in a 12-year-old girl. Discuss in brief the clinical manifestations and laboratory findings (DNB 2012/1)3+4+3 | 603 | 2012 |
| Clinical features, investigation and treatment of congenital hypothyroidism (DNB 2016/2)10 | 603 | 2016 |
| Screening and treatment of congenital hypothyroidism (DNB 2018/1)6 | 603 | 2018 |
| Clinical features, investigation and treatment of congenital hypothyroidism (DNB 2018/2)5 | 603 | 2018 |
| Congenital hypothyroidism: Etiology, Diagnosis and Management (DNB 2022/1)5 | 603 | 2022 |
| Congenital Hypothyroidism (DNB 2022/2)5 | 603 | 2022 |
| Management of congenital hypothyroidism (DNB 2023/1)5 | 603 | 2023 |
| Briefly list the various thyroid function tests. Describe clinical presentation and management of autoimmune thyroiditis (DNB 2004/2)6+4 | 604 | 2004 |
| Clinical features and management of Hashimoto's thyroiditis (DNB 2016/1)5 | 604 | 2016 |
| Hashimoto's thyroiditis (DNB 2020/1)5 | 604 | 2020 |
| Chronic lymphocytic thyroiditis (DNB 2023/2)5 | 604 | 2023 |
| Management of Puberty Goiter (DNB 1993/1)15 | 605 | 1993 |
| Management of Puberty Goiter (DNB 1998/2)15 | 605 | 1998 |
| Goitrogenic Hypothyroidism (DNB 2003/2)15 | 605 | 2003 |
| Role of hormones in calcium balance (DNB 2003/2)15 | 610 | 2003 |
| Outline the calcium metabolism. Discuss the causes and management of Hypocalcaemia in 3 years old (DNB 2007/2)10 | 610 | 2007 |
| Define hypocalcemia. Enumerate hormones affecting calcium balance in the body. Describe the respective roles in calcium homeostasis (DNB 2013/1)2+3+5 | 610 | 2013 |
| Calcium regulation in humans (DNB 2018/2)5 | 610 | 2018 |
| Calcium homeostasis during normal health (DNB 2021/1)5 | 610 | 2021 |
| Differentiate between the laboratory features of hypoparathyroidism, pseudohypoparathyroidism and hyperparathyroidism (DNB 2008/1)10 | 611 | 2008 |
| Differentiate between the laboratory features of hypoparathyroidism, pseudohypoparathyroidism and hyperparathyroidism (DNB 2012/1)10 | 611 | 2012 |
| Describe the calcium metabolism in a child. Detail the clinical manifestation, diagnosis and treatment of a child with pseudohypoparathyroidism (DNB 2008/2)10 | 612 | 2008 |
| Discuss the etiopathogenesis, clinical manifestations, diagnosis and treatment of hypercalcemia (DNB 2009/1)10 | 613 | 2009 |
| a) Adrenal steroid hormone synthesis b) Outline steps involved in synthesis of steroid hormones (DNB 2016/1)5+5 | 614 | 2016 |
| Steroid biosynthesis pathway (DNB 2017/2)4 | 614 | 2017 |
| Steroidogenic pathway (DNB 2018/2)5 | 614 | 2018 |
| Causes of Adrenal Crises and discuss its management (DNB 2006/1)10 | 615 | 2006 |
| Enumerate the causes of adrenal crisis. Provide key features of clinical presentation and discuss its management (DNB 2008/1)10 | 615 | 2008 |
| Enumerate causes and management of adrenal crisis (DNB 2016/1)5 | 615 | 2016 |
| Management of adrenogenital syndrome (DNB 1996/2)15 | 616 | 1996 |
| Salt losing CAH (DNB 2003/1)15 | 616 | 2003 |
| Diagnosis and management of a child with CAH (DNB 2006/1)10 | 616 | 2006 |
| Clinical features & management of classical congenital hyperplasia (DNB 2016/1)4+3 | 616 | 2016 |
| Outline biochemical consequences of defects in the classical 21- hydroxylase deficiency and its management (DNB 2016/1)2+3 | 616 | 2016 |
| Clinical features of CAH (DNB 2017/2)6 | 616 | 2017 |
| Management of CAH (DNB 2017/1)5 | 616 | 2017 |
| Diagnosis and prevention of congenital adrenal hyperplasia (CAH) (DNB 2020/1)5 | 616 | 2020 |
| Clinical features of classical CAH (DNB 2023/1)5 | 616 | 2023 |
| Describe the pathway of steroid hormone production by adrenal cortex and the abnormalities due to various biochemical defects causing congenital adrenal hyperplasia (DNB 2024/2)5 | 616 | 2024 |
| A 1½ year old female is brought to you with obesity, short stature, hypertension and hypertrichosis of face and trunk. Provide differential diagnosis and approach to investigating and managing this child (DNB 2009/1)3+7 | 619 | 2009 |
| Clinical features, investigations & treatment of pheochromocytoma (DNB 2010/1)3+3+4 | 621 | 2010 |
| Describe normal sexual differentiation in fetus. What is intersex? Describe etiological Classification of disorders of Sex Development (DSD) (DNB 2011/2)2+2+6 | 622 | 2011 |
| Short note on female with Ambiguous genitalia at birth (DNB 2002/1)15 | 628 | 2002 |
| Outline human sex differentiation. Provide an outline of the approach to an infant with ambiguous genitalia (DNB 2004/2)4+6 | 628 | 2004 |
| Explain synthesis of Steroid Hormones. Discuss Briefly approach to a child born with ambiguous genitalia (DNB 2005/1)5+5 | 628 | 2005 |
| Discuss approach to a child with ambiguous Genitalia (DNB 2006/2)10 | 628 | 2006 |
| Discuss karyotype abnormalities, clinical features and management of true hermaphroditism (DNB 2008/1)10 | 628 | 2008 |
| Describe the diagnostic approach in a 2-year-old child with ambiguous genitalia (DNB 2009/2)10 | 628 | 2009 |
| A) Define disorders of sexual differentiation (DSD) in new born B) Nursery evaluation of a newborn with suspected DSD by history, physical examination and diagnostic tests C) Issues in management of DSD (DNB 2015/1)2+6+2 | 628 | 2015 |
| Approach to a neonate with Disorder of Sexual Development (DNB 2022/1)5 | 628 | 2022 |
| What are the disorders of sexual development (DSD)? Give etiological classification of DSD (DNB 2024/2)5 | 628 | 2024 |
| Baby suffering with DSD (disorders of sexual development): a) Etiopathogenesis b) Clinical features c) Management (DCH 2024/2)3+3+4 | 628 | 2024 |
| Emergency management of DKA (DNB 1993/1)15 | 629 | 1993 |
| Management of DKA (DNB 1995/2)15 | 629 | 1995 |
| Complications of Juvenile Diabetes Mellitus and their management (DNB 1997/1)15 | 629 | 1997 |
| Describe briefly the biochemical changes and management of DKA (DNB 1998/1)25 | 629 | 1998 |
| 8 years old with history of vomiting, severe abdominal pain for 2 days. Dehydrated, acidotic breathing, Blood glucose (random) 400. Outline the management (DNB 2005/1)10 | 629 | 2005 |
| Write management of DKA (DNB 2006/1)5 | 629 | 2006 |
| Management of a child with IDDM (DNB 2006/2)10 | 629 | 2006 |
| Write risk factors, pathogenesis and treatment of Type 2 Diabetes Mellitus in children (DNB 2007/2)10 | 629 | 2007 |
| Classify severity of diabetic ketoacidosis on the basis of clinical and blood gas examination. Briefly describe Somogyi and Dawn phenomenon in type 1 diabetes (DNB 2008/1)10 | 629 | 2008 |
| Discuss the metabolic changes associated with diabetic ketoacidosis with steps of treatment of diabetic ketoacidosis (DNB 2008/2)10 | 629 | 2008 |
| A 10-year-old child (body weight 22kg) presents with severe diabetic ketoacidosis. Write down the expected clinical and investigate findings. Outline the plan of management in first 24 hours (DNB 2009/1)4+6 | 629 | 2009 |
| What are the biochemical criteria for the diagnosis of Diabetic Ketoacidosis (DKA)? What are the goals of therapy? How will you manage a 7-year-old child with DKA? (DNB 2011/2)3+3+4 | 629 | 2011 |
| Discuss the pathophysiological abnormalities in diabetic ketoacidosis. Describe the management of diabetic ketoacidosis in a child weighing 20 kg (DNB 2013/2)4+6 | 629 | 2013 |
| A. What are the biochemical criteria for the diagnosis of Diabetic Ketoacidosis (DKA)? B. What are the goals of therapy?C. How will you manage a child with DKA? (DNB 2016/1)3+2+5 | 629 | 2016 |
| Diagnosis and complication of Metabolic syndrome (DNB 2016/1)4 | 629 | 2016 |
| Hyperosmolar non ketotic diabetic coma (DNB 2016/1)5 | 629 | 2016 |
| Commonly used insulin regimens for long treatment of type 1 Diabetes Mellitus (DNB 2017/2)5 | 629 | 2017 |
| Management of diabetic ketoacidosis (DNB 2018/1)5 | 629 | 2018 |
| Management of treatment of diabetes at home (DNB 2019/1)5 | 629 | 2019 |
| Long-term management of Type 1 diabetes mellitus (DNB 2020/1)5 | 629 | 2020 |
| Recent advances in insulin therapy (DNB 2021/1)5 | 629 | 2021 |
| Continuous glucose monitoring systems (DNB 2021/1)5 | 629 | 2021 |
| Diabetic Ketoacidosis - Management (DNB 2021/2)6 | 629 | 2021 |
| Insulin Analogues (DNB 2021/2)5 | 629 | 2021 |
| Pathophysiology of Diabetic Ketoacidosis (DNB 2022/1)5 | 629 | 2022 |
| Management of childhood diabetes (DNB 2022/1)5 | 629 | 2022 |
| Recent advances in insulin therapy (DNB 2023/1)5 | 629 | 2023 |
| DKA diagnostic criteria (DCH 2023/2)5 | 629 | 2023 |
| DKA management in 20 kg child (DCH 2023/2)5 | 629 | 2023 |
| Long term management of Type 1 diabetes mellitus (excluding DKA) (DNB 2023/2)5 | 629 | 2023 |
| Management of diabetic ketoacidosis (DNB 2023/2)5 | 629 | 2023 |
| Commonly used insulin regimens for long treatment of type 1 Diabetes Mellitus (DNB 2024/1)5 | 629 | 2024 |
| Components of metabolic syndrome in children (DNB 2024/1)5 | 629 | 2024 |
| Nutritional management of an adolescent with type-1 Diabetes (DNB 2024/1)5 | 629 | 2024 |
| Outline management of diabetic ketoacidosis (DNB 2024/2)5 | 629 | 2024 |
| Approach to precocious puberty in a 6-year-old boy: diagnosis and management (DNB 2024/2)5 | 600 | 2024 |
| Pathway of steroid hormone production by adrenal cortex and CAH biochemical defects (DNB 2024/2)5 | 616 | 2024 |
| Screening tests for diagnosis of Cushing's syndrome in children (DNB 2025/1)5 | 619 | 2025 |
| Hyperaldosteronism in a child (etiology, diagnosis with lab tests) (DNB 2025/1)5 | 620 | 2025 |
| Diagnosis of pheochromocytoma in a child (DNB 2025/1)5 | 621 | 2025 |
| Disorders of sexual development (DSD); etiological classification (DNB 2024/2)5 | 628 | 2024 |
| Management of diabetic ketoacidosis (DKA) (DNB 2024/2)5 | 629 | 2024 |